Pfizer (PFE): Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a partial sale $1K–$15K

$1,001–$15,000

Reported range · official band, not an exact amount

38 days

Disclosure lag

Traded

Aug 5, 2025

Disclosed

Sep 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 30, 2025CongressDisclosed purchase of PFE — reported range $1,001 - $15,000
2. Jun 3, 2025Congress · 2 peopleMembers of Congress: 2 sales
3. Jun 12, 2025FDAFDA drug approval: Talzenna
4. Jun 12, 2025FDAFDA drug approval: Talzenna
5. Jul 10, 2025FDAFDA drug approval: Elrexfio
6. Jul 10, 2025FDARecall: Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001. Made…
7. Jul 10, 2025FDARecall: Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made…
8. Jul 16, 2025CongressDisclosed purchase of PFE — reported range $1,001 - $15,000
9. Jul 29, 2025FDARecall: Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851…
10. Aug 4, 2025FDARecall: Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05. Case: NDC 04…
11. Aug 4, 2025FDARecall: Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 004…
12. Aug 4, 2025CongressDisclosed sale of PFE — reported range $1,001 - $15,000
13. Aug 5, 2025 · this disclosureCongressDisclosed partial sale of PFE — reported range $1,001 - $15,000

What came next

1. Aug 25, 2025Layoff notice · BothellLayoff notice filed in WA: 100 employees
2. Sep 11, 2025FDAFDA drug approval: Potassium Phosphates
3. Sep 16, 2025FDAFDA drug approval: Ibrance
4. Sep 16, 2025FDAFDA drug approval: Ibrance
5. Oct 16, 2025FDAFDA drug approval: Xeljanz
6. Nov 4, 2025Company filing · Form 8-K · ResultsReported its results
7. Nov 26, 2025Government · Federal Register noticeForeign-Trade Zone (FTZ) 43; Authorization of Limited Production Activity; Pfizer, Inc.; (Pharmaceutical Intermediate Product); Kalamazoo, Michigan

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Pfizer

OQRO holds no insider, Congress, fund or contract record for Pfizer dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PFE page.

Other recent filings by Rep. Gilbert Ray Cisneros Jr. (CA31)

• House Clerk periodic transaction report at Alexandria Real Estate Equities (ARE)Nov 10, 2026
• House Clerk periodic transaction report at Alliant Energy (LNT)Nov 10, 2026
• House Clerk periodic transaction report at AppLovin (APP)Nov 10, 2026
• House Clerk periodic transaction report at AppLovin (APP)Nov 10, 2026
• House Clerk periodic transaction report at Argenx (ARGX)Nov 10, 2026

The full history of Rep. Gilbert Ray Cisneros Jr. (CA31) is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at Pfizer

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its PFE page.